Short seller Andrew Left has his doubts about Canadian pot stocks, says he's betting against Canopy
November 14, 2018 at 14:38 PM EST
Citron Research's Andrew left reiterated his bet against the Canadian cannabis industry, telling CNBC that he's short Canopy Growth and Cronos Group in addition to his already disclosed wager against Tilray.